Reach Us +44-7482878454
The Effects of Fetal and Childhood Exposure to Antiretroviral Agents | OMICS International | Abstract
ISSN 2155-6113

Journal of AIDS & Clinical Research
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

The Effects of Fetal and Childhood Exposure to Antiretroviral Agents

Catherine M. Mas, Tracie L. Miller, Christina Cordero, Danielle Dauphin, Marie Boursiquot White, Christie K. Vila, Gabriel Somarriba, James D. Wilkinson and Steven E. Lipshultz*

The Department of Pediatrics, University of Miami Miller School of Medicine, Miami FL, USA

*Corresponding Author:
Steven E. Lipshultz, MD
Department of Pediatrics (D80)
University of Miami Miller School of Medicine
P.O. Box 016820 Miami, FL, USA
Tel: 305 243-3993
Fax: 305 243-399
E-mail: [email protected]

Received Date: August 05, 2011; Accepted Date: October 17, 2011; Published Date: October 20, 2011

Citation: Mas CM, Miller TL, Cordero C, Dauphin D, White MB, et al. (2011) The Effects of Fetal and Childhood Exposure to Antiretroviral Agents. J AIDS Clinic Res S2:001. doi:10.4172/2155-6113.S2-001

Copyright: © 2011 Mas CM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credit ed.


Purpose: The compliant use of combination antiretroviral therapy has virtually eliminated perinatal HIV transmission. Although antiretroviral drug toxicities in adults have been well documented, the effects of fetal and early childhood exposure to antiretroviral drugs on children of HIV-positive mothers are not well known. Methods: We searched the Pub Med database, reviewed publications, and selected abstracts on the use of antiretroviral agents to prevent HIV transmission and their effects on growth and cardiac endpoints in fetal and postnatal life. Results: The link between nucleoside analogs and mitochondrial dysfunction is controversial, and the association between in utero antiretroviral exposure and mitochondrial dysfunction in children is unclear. In utero exposure to antiretroviral therapy has effects on the heart, regardless of HIV status, including improved cardiac function but also reduced cardiac mass of unclear future clinical significance. Preterm delivery and impaired somatic growth have been reported in infants exposed to antiretrovirals, but results are inconsistent. In utero exposure has also been associated with below-normal hematologic parameters. In HIV-infected children, cumulative postnatal exposure to antiretroviral agents is associated with metabolic disturbances and an increased risk for cardiovascular disease. Conclusion: Antiretroviral therapy is effective in preventing perinatal HIV transmission but may be associated with adverse long-term side effects in exposed infants. Further clinical trials and longitudinal monitoring are needed to understand the long-term effects of in utero exposure to antiretroviral agents.